tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

MTVA Stock Latest News

MetaVia announces presentation of pre-clinical data on DA-1241
The FlyMetaVia announces presentation of pre-clinical data on DA-1241
7d ago
MTVA
MetaVia Faces Nasdaq Delisting Notice for Low Stock Price
PremiumCompany Announcements
MetaVia Faces Nasdaq Delisting Notice for Low Stock Price
1M ago
8K
MTVA
MetaVia Reports Progress in Obesity and MASH Treatments
PremiumCompany Announcements
MetaVia Reports Progress in Obesity and MASH Treatments
1M ago
MTVA
MetaVia Updates Corporate Presentation on DA-1726 Progress
PremiumCompany Announcements
MetaVia Updates Corporate Presentation on DA-1726 Progress
1M ago
8K
MTVA
MetaVia price target lowered to $3 from $6 at Maxim
PremiumThe Fly
MetaVia price target lowered to $3 from $6 at Maxim
1M ago
MTVA
MetaVia Completes $10 Million Private Placement
PremiumCompany AnnouncementsMetaVia Completes $10 Million Private Placement
2M ago
8K
MTVA
MetaVia announces $10M private placement
Premium
The Fly
MetaVia announces $10M private placement
2M ago
MTVA
MetaVia Unveils Promising DA-1241 Trial Results
Premium
Company Announcements
MetaVia Unveils Promising DA-1241 Trial Results
2M ago
8K
MTVA
MetaVia announces data from DA-1241 trial at EASL
PremiumThe Fly
MetaVia announces data from DA-1241 trial at EASL
2M ago
MTVA
MetaVia’s Promising Clinical Trial Results and Future Prospects Drive Buy Rating
PremiumRatings
MetaVia’s Promising Clinical Trial Results and Future Prospects Drive Buy Rating
2M ago
MTVA
MetaVia Reports Positive Phase 1 Trial Results
PremiumCompany Announcements
MetaVia Reports Positive Phase 1 Trial Results
2M ago
8K
MTVA
MetaVia’s DA-1726 obesity candidate shows efficacy in Part 2 of Phase 1 study
PremiumThe Fly
MetaVia’s DA-1726 obesity candidate shows efficacy in Part 2 of Phase 1 study
2M ago
MTVA
MetaVia’s DA-1726: Promising Weight Loss Solution with Strong Buy Potential Despite Market Overreaction
PremiumRatingsMetaVia’s DA-1726: Promising Weight Loss Solution with Strong Buy Potential Despite Market Overreaction
2M ago
MTVA
Promising Clinical Trial Results for MetaVia’s DA-1726: A Potential Leading Weight Loss Therapy
Premium
Ratings
Promising Clinical Trial Results for MetaVia’s DA-1726: A Potential Leading Weight Loss Therapy
2M ago
MTVA
MetaVia Announces Positive Phase 1 Trial Results
Premium
Company Announcements
MetaVia Announces Positive Phase 1 Trial Results
3M ago
8K
MTVA
MetaVia announces ‘positive’ results from Part 2 of Phase 1 trial of DA-1726
PremiumThe Fly
MetaVia announces ‘positive’ results from Part 2 of Phase 1 trial of DA-1726
3M ago
MTVA
Positive Outlook on MetaVia’s Promising Pipeline and Strategic Growth Despite Market Challenges
PremiumRatings
Positive Outlook on MetaVia’s Promising Pipeline and Strategic Growth Despite Market Challenges
3M ago
MTVA
MetaVia Inc. Reports Progress in Cardiometabolic Drug Development
PremiumCompany Announcements
MetaVia Inc. Reports Progress in Cardiometabolic Drug Development
3M ago
MTVA
MetaVia’s Promising Clinical Developments and Strategic Advancements Drive Buy Recommendation
PremiumRatings
MetaVia’s Promising Clinical Developments and Strategic Advancements Drive Buy Recommendation
3M ago
MTVA
MetaVia Advances Therapeutics with Promising Trial Updates
PremiumCompany AnnouncementsMetaVia Advances Therapeutics with Promising Trial Updates
6M ago
8K
MTVA
MetaVia initiated with a Buy at H.C. Wainwright
Premium
The Fly
MetaVia initiated with a Buy at H.C. Wainwright
6M ago
MTVA
MetaVia Reports Positive Phase 2a Clinical Trial Results
Premium
Company Announcements
MetaVia Reports Positive Phase 2a Clinical Trial Results
6M ago
8K
MTVA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >